WO2002070685A3 - Verfahren zur veränderung des genoms von gram-positiven bakterien mit einem neuen konditional negativ dominanten markergen - Google Patents

Verfahren zur veränderung des genoms von gram-positiven bakterien mit einem neuen konditional negativ dominanten markergen Download PDF

Info

Publication number
WO2002070685A3
WO2002070685A3 PCT/EP2002/002133 EP0202133W WO02070685A3 WO 2002070685 A3 WO2002070685 A3 WO 2002070685A3 EP 0202133 W EP0202133 W EP 0202133W WO 02070685 A3 WO02070685 A3 WO 02070685A3
Authority
WO
WIPO (PCT)
Prior art keywords
modifying
genome
gram
marker gene
positive bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/002133
Other languages
English (en)
French (fr)
Other versions
WO2002070685A2 (de
Inventor
Markus Pompejus
Burkhard Kroeger
Hartwig Schroeder
Oskar Zelder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AU2002251038A priority Critical patent/AU2002251038A1/en
Priority to CA002439684A priority patent/CA2439684A1/en
Priority to US10/467,479 priority patent/US20040115816A1/en
Priority to KR1020037011376A priority patent/KR100868691B1/ko
Priority to EP02719954A priority patent/EP1368480B1/de
Priority to DE50206566T priority patent/DE50206566D1/de
Application filed by BASF SE filed Critical BASF SE
Priority to JP2002570712A priority patent/JP2004522450A/ja
Publication of WO2002070685A2 publication Critical patent/WO2002070685A2/de
Publication of WO2002070685A3 publication Critical patent/WO2002070685A3/de
Anticipated expiration legal-status Critical
Priority to US11/476,404 priority patent/US20100240131A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C12N9/1055—Levansucrase (2.4.1.10)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/77—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Die Erfindung betrifft ein neues Verfahren zur Veränderung des Genoms von gram-positiven Bakterien, diese Bakterien und neue Vektoren. Insbesondere betrifft die Erfindung ein Verfahren zur Veränderung von Corynebacterien oder Brevibacterien mit Hilfe eines neuen in den Bakterien konditional negativ dominant wirkenden Markergens.
PCT/EP2002/002133 2001-03-01 2002-02-28 Verfahren zur veränderung des genoms von gram-positiven bakterien mit einem neuen konditional negativ dominanten markergen Ceased WO2002070685A2 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CA002439684A CA2439684A1 (en) 2001-03-01 2002-02-28 Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene
US10/467,479 US20040115816A1 (en) 2001-03-01 2002-02-28 Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene
KR1020037011376A KR100868691B1 (ko) 2001-03-01 2002-02-28 신규한 조건부 음성 우성 마커 유전자에 의한 그람-양성박테리아 게놈의 변형 방법
EP02719954A EP1368480B1 (de) 2001-03-01 2002-02-28 Verfahren zur veränderung des genoms von gram-positiven bakterien mit einem neuen konditional negativ dominanten markergen
DE50206566T DE50206566D1 (de) 2001-03-01 2002-02-28 Verfahren zur veränderung des genoms von gram-positiven bakterien mit einem neuen konditional negativ dominanten markergen
AU2002251038A AU2002251038A1 (en) 2001-03-01 2002-02-28 Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene
JP2002570712A JP2004522450A (ja) 2001-03-01 2002-02-28 新規の条件付きで負に優性のマーカー遺伝子によるグラム陽性細菌ゲノムの修飾方法
US11/476,404 US20100240131A1 (en) 2001-03-01 2006-06-28 Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10109996A DE10109996A1 (de) 2001-03-01 2001-03-01 Verfahren zur Veränderung des Genoms von gram-positiven Bakterien mit einem neuen konditional negativ dominanten Markergen
DE10109996.7 2001-03-01

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/476,404 Continuation US20100240131A1 (en) 2001-03-01 2006-06-28 Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene

Publications (2)

Publication Number Publication Date
WO2002070685A2 WO2002070685A2 (de) 2002-09-12
WO2002070685A3 true WO2002070685A3 (de) 2003-01-23

Family

ID=7676017

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/002133 Ceased WO2002070685A2 (de) 2001-03-01 2002-02-28 Verfahren zur veränderung des genoms von gram-positiven bakterien mit einem neuen konditional negativ dominanten markergen

Country Status (11)

Country Link
US (2) US20040115816A1 (de)
EP (1) EP1368480B1 (de)
JP (1) JP2004522450A (de)
KR (1) KR100868691B1 (de)
AT (1) ATE324453T1 (de)
AU (1) AU2002251038A1 (de)
CA (1) CA2439684A1 (de)
DE (2) DE10109996A1 (de)
DK (1) DK1368480T3 (de)
ES (1) ES2259703T3 (de)
WO (1) WO2002070685A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005032429A1 (de) 2005-01-19 2006-07-20 Degussa Ag Allele des mqo-Gens aus coryneformen Bakterien
DE102005013676A1 (de) 2005-03-24 2006-09-28 Degussa Ag Allele des zwf-Gens aus coryneformen Bakterien
DE102005023829A1 (de) 2005-05-24 2006-11-30 Degussa Ag Allele des opcA-Gens aus coryneformen Bakterien
DE102006032634A1 (de) 2006-07-13 2008-01-17 Evonik Degussa Gmbh Verfahren zur Herstellung von L-Aminosäuren
DE102008001874A1 (de) 2008-05-20 2009-11-26 Evonik Degussa Gmbh Verfahren zur Herstellung von L-Aminosäuren
CN108463546B (zh) * 2015-12-11 2022-03-11 瓦克化学股份公司 用于无抗生素发酵制备低分子量物质和蛋白质的微生物菌株和方法
EP3415622A1 (de) 2017-06-14 2018-12-19 Evonik Degussa GmbH Verfahren zur herstellung von feinchemikalien mittels eines corynebakteriums, welches modifizierte alpha-1,6-glucosidasen sezerniert
EP3456833A1 (de) 2017-09-18 2019-03-20 Evonik Degussa GmbH Methode zur fermentativen production von l-aminosäuren
RU2019128538A (ru) 2018-09-26 2021-03-11 Эвоник Оперейшенс ГмбХ Способ ферментативного получения l-лизина

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991000913A1 (en) * 1989-07-07 1991-01-24 E.I. Du Pont De Nemours And Company Inducible expression vectors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0693558B1 (de) * 1994-07-19 2002-12-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Trehalose, ihre Herstellung und ihre Verwendung
US6423545B1 (en) * 1999-07-08 2002-07-23 Albert Einstein College Of Medicine Of Yeshiva University Unmarked deletion mutants of mycobacteria and methods of using same
US6673567B2 (en) * 2000-03-23 2004-01-06 E. I. Du Pont De Nemours And Company Method of determination of gene function

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991000913A1 (en) * 1989-07-07 1991-01-24 E.I. Du Pont De Nemours And Company Inducible expression vectors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SCHAEFER A ET AL: "SMALL MOBILIZABLE MULTI-PURPOSE CLONING VECTORS DERIVED FROM THE ESCHERICHIA COLI PLASMIDS PK18 AND PK19: SELECTION OF DEFINED DELETIONS IN THE CHROMOSOME OF CORYNEBACTERIUM GLUTAMICUM", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 145, no. 145, 1994, pages 69 - 73, XP001093898, ISSN: 0378-1119 *
TANG L B ET AL: "ISOLATION AND CHARACTERIZATION OF LEVANSUCRASE-ENCODING GENE FROM BACILLUS AMYLOLIQUEFACIENS", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 96, 1990, pages 89 - 93, XP000651635, ISSN: 0378-1119 *

Also Published As

Publication number Publication date
DE10109996A1 (de) 2002-09-05
EP1368480A2 (de) 2003-12-10
EP1368480B1 (de) 2006-04-26
JP2004522450A (ja) 2004-07-29
US20040115816A1 (en) 2004-06-17
KR100868691B1 (ko) 2008-11-13
AU2002251038A1 (en) 2002-09-19
CA2439684A1 (en) 2002-09-12
WO2002070685A2 (de) 2002-09-12
KR20030080242A (ko) 2003-10-11
DK1368480T3 (da) 2006-07-10
ATE324453T1 (de) 2006-05-15
ES2259703T3 (es) 2006-10-16
DE50206566D1 (de) 2006-06-01
US20100240131A1 (en) 2010-09-23

Similar Documents

Publication Publication Date Title
EP1208085A4 (de) Benzanilide als öffner des kaliumkanals
WO2004033659A3 (en) Novel tumor suppressor gene and compositions and methods for making and using the same
WO2001064920A3 (en) Hybrid expression of neisserial proteins
MXPA03011329A (es) Antiinfecciosos novedosos.
SI1601776T1 (sl) Ekspresijski vektorji, ki vsebujejo mcmv ie2 promotor
MXPA03001823A (es) Cepa bacteriana metanotrofica de alto crecimiento methylomonas 16a.
ATE448303T1 (de) Vektoren zur gerichteten klonierung
WO2003099217A3 (en) Methods of treating bacterial infections and diseases associated therewith
WO2002070685A3 (de) Verfahren zur veränderung des genoms von gram-positiven bakterien mit einem neuen konditional negativ dominanten markergen
WO2004099235A3 (en) Bacteriocins and novel bacterial strains
AU2002213937A1 (en) Method for modifying the genome of corynebacteria
PL2192115T3 (pl) 1,3-dimetylobutylokarboksyanilidy do zwalczania niepożądanych mikroorganizmów
AU2003304255A1 (en) Genetic marker for live bacterial vaccines
AU2003247279A1 (en) Furancarboxamides
PL376576A1 (pl) Tiazolo(bi)cykloalkilokarboksyanilidy
WO2005087932A3 (en) Vectors for directional cloning
AU2002214155A1 (en) Bacterial control by bacteriophages
DE69916081D1 (en) Nicht-homologues yarrowia lipolytica transformationsverfahren
PL378118A1 (pl) Oksatiinokarboksyamisy
AU2003232775A1 (en) Oxathiincarboxamides
MXPA03010498A (es) Proceso para la preparacion de imipenem.
WO2002068682A3 (de) Verfahren zur identifizierung biologisch aktiver strukturen mikrobieller erreger
WO2004020640A3 (fr) Cassettes d'expression procaryotes regulees par le zinc
ZA200501194B (en) Plasmid-free clone of e. coli strain dsm 6601
PL372933A1 (en) Methylthiophene carboxanilides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002719954

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10467479

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2002570712

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2439684

Country of ref document: CA

Ref document number: 1020037011376

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1020037011376

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2002719954

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2002719954

Country of ref document: EP